Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
MacLean et al.
Chest 2012;141:e1S-e23S.
ABSTRACT
| FULL TEXT
Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
Pink et al.
BMJ 2011;343:d6333-d6333.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
Shah and Gage
Circulation 2011;123:2562-2570.
ABSTRACT
| FULL TEXT
Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Jowett et al.
Stroke 2011;42:1717-1721.
ABSTRACT
| FULL TEXT
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
Lip et al.
Europace 2011;13:723-746.
ABSTRACT
| FULL TEXT
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2011;57:e101-e198.
FULL TEXT
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Fuster et al.
Circulation 2011;123:e269-e367.
FULL TEXT
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
Freeman et al.
ANN INTERN MED 2011;154:1-11.
ABSTRACT
| FULL TEXT
Moving the Tipping Point: The Decision to Anticoagulate Patients With Atrial Fibrillation
Eckman et al.
Circ Cardiovasc Qual Outcomes 2011;4:14-21.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
Patrick et al.
Circ Cardiovasc Qual Outcomes 2009;2:429-436.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Therapeutic Hypothermia After Cardiac Arrest
Merchant et al.
Circ Cardiovasc Qual Outcomes 2009;2:421-428.
ABSTRACT
| FULL TEXT
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Pletcher et al.
ANN INTERN MED 2009;150:243-254.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Eckman et al.
ANN INTERN MED 2009;150:73-83.
ABSTRACT
| FULL TEXT
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? * Supplemental Appendix
Eckman et al.
Stroke 2008;39:3308-3315.
ABSTRACT
| FULL TEXT
Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage: The FUNC Score
Rost et al.
Stroke 2008;39:2304-2309.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT
| FULL TEXT
Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
Garwood and Corbett
The Annals of Pharmacotherapy 2008;42:523-532.
ABSTRACT
| FULL TEXT
Consent for Intravenous Thrombolysis in Acute Stroke: Review and Future Directions
White-Bateman et al.
Arch Neurol 2007;64:785-792.
ABSTRACT
| FULL TEXT
Incremental Benefit and Cost-Effectiveness of High-Dose Statin Therapy in High-Risk Patients With Coronary Artery Disease
Chan et al.
Circulation 2007;115:2398-2409.
ABSTRACT
| FULL TEXT
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT
Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II-Eligible Population
Chan et al.
J Am Coll Cardiol 2006;48:112-121.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Chan et al.
J Am Coll Cardiol 2006;47:2513-2520.
ABSTRACT
| FULL TEXT
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making
Man-Son-Hing et al.
Med Decis Making 2005;25:548-559.
ABSTRACT
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
Dunn et al.
Med Decis Making 2005;25:387-397.
ABSTRACT
Cost-effectiveness of Ximelagatran for Stroke Prevention
Perret-Guillaume and Wahl
JAMA 2005;293:2860-2861.
FULL TEXT
Cost-effectiveness of Ximelagatran for Stroke Prevention--Reply
O'Brien and Gage
JAMA 2005;293:2861-2861.
FULL TEXT
Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation
Miller et al.
Eur Heart J Suppl 2005;7:C41-C54.
ABSTRACT
| FULL TEXT
A Cost-Effectiveness Analysis of Combination Antiplatelet Therapy for High-Risk Acute Coronary Syndromes: Clopidogrel plus Aspirin versus Aspirin Alone
Schleinitz and Heidenreich
ANN INTERN MED 2005;142:251-259.
ABSTRACT
| FULL TEXT
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
O'Brien and Gage
JAMA 2005;293:699-706.
ABSTRACT
| FULL TEXT
Ximelagatran--Promises and Concerns
Gurewich
JAMA 2005;293:736-739.
FULL TEXT
A Comparison of 3 Valuation Methods for Temporary Health States in Patients Treated with Oral Anticoagulants
Locadia et al.
Med Decis Making 2004;24:625-633.
ABSTRACT
Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
Gage et al.
Circulation 2004;110:2287-2292.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Singer et al.
Chest 2004;126:429S-456S.
ABSTRACT
| FULL TEXT
ACC/AHA Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation)
Endorsed by the Mediterranean Society of Pacing an et al.
Circulation 2004;109:3223-3243.
FULL TEXT
Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs
Sandercock et al.
Stroke 2004;35:1490-1497.
ABSTRACT
| FULL TEXT
Regionalization of Treatment for Subarachnoid Hemorrhage: A Cost-Utility Analysis
Bardach et al.
Circulation 2004;109:2207-2212.
ABSTRACT
| FULL TEXT
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
McNamara et al.
ANN INTERN MED 2003;139:1018-1033.
ABSTRACT
| FULL TEXT
A 60-Year-Old Woman With Atrial Fibrillation
Singer
JAMA 2003;290:2182-2189.
FULL TEXT
Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations
Stahl et al.
Radiology 2003;228:659-668.
ABSTRACT
| FULL TEXT
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis
Eckman et al.
Stroke 2003;34:1710-1716.
ABSTRACT
| FULL TEXT
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation: An Individual Patient Meta-analysis
van Walraven et al.
JAMA 2002;288:2441-2448.
ABSTRACT
| FULL TEXT
Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial
Koops and Lindley
BMJ 2002;325:415-415.
ABSTRACT
| FULL TEXT
Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis
Eckman et al.
Med Decis Making 2002;22:108-124.
ABSTRACT
Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation
Man-Son-Hing and Laupacis
Arch Intern Med 2002;162:541-550.
ABSTRACT
| FULL TEXT
Seniors' Preferences for Cancer Screening and Medication Use Based on Absolute Risk Reduction
Murphy et al.
J Gerontol A Biol Sci Med Sci 2002;57:M100-M105.
ABSTRACT
| FULL TEXT
Prevalence and Quality of Warfarin Use for Patients With Atrial Fibrillation in the Long-term Care Setting
McCormick et al.
Arch Intern Med 2001;161:2458-2463.
ABSTRACT
| FULL TEXT
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1266-1266.
FULL TEXT
Cost-effectiveness of Automated External Defibrillators on Airlines
Groeneveld et al.
JAMA 2001;286:1482-1489.
ABSTRACT
| FULL TEXT
Understanding patients' preferences for treatment: the need for innovative methodologies
Frewer et al.
BMJQS 2001;10:i50-54.
ABSTRACT
| FULL TEXT
Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A
Marchetti et al.
QJM 2001;94:365-372.
ABSTRACT
| FULL TEXT
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage et al.
JAMA 2001;285:2864-2870.
ABSTRACT
| FULL TEXT
The Utility of Health States After Stroke : A Systematic Review of the Literature
Post et al.
Stroke 2001;32:1425-1429.
ABSTRACT
| FULL TEXT
Effect of experience of severe stroke on subjective valuations of quality of life after stroke
Murphy et al.
J. Neurol. Neurosurg. Psychiatry 2001;70:679-681.
ABSTRACT
| FULL TEXT
Health-Related Quality of Life After Stroke A Comprehensive Review Editorial Comment : Health-Related Quality Of Life After Stroke: A Comprehensive Review
Tengs et al.
Stroke 2001;32:964-972.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy in Atrial Fibrillation
Albers et al.
Chest 2001;119:194S-206S.
FULL TEXT
The potential use of decision analysis to support shared decision making in the face of uncertainty: the example of atrial fibrillation and warfarin anticoagulation
Robinson and Thomson
BMJQS 2000;9:238-244.
ABSTRACT
| FULL TEXT
Stroke patients' views on stroke outcomes: death versus disability
Hanger et al.
Clin Rehabil 2000;14:417-424.
ABSTRACT
Parents' Utilities for Outcomes of Occult Bacteremia
Bennett et al.
Arch Pediatr Adolesc Med 2000;154:43-48.
ABSTRACT
| FULL TEXT
Assessing Convergent Validity of Health-state Utilities Obtained Using Different Scaling Methods
Nickerson
Med Decis Making 1999;19:487-498.
ABSTRACT
A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation: A Randomized Controlled Trial
Man-Son-Hing et al.
JAMA 1999;282:737-743.
ABSTRACT
| FULL TEXT
Which unruptured cerebral aneurysms should be treated?: A cost-utility analysis
Johnston et al.
Neurology 1999;52:1806-1806.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation
Catherwood et al.
ANN INTERN MED 1999;130:625-636.
ABSTRACT
| FULL TEXT
Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls
Man-Son-Hing et al.
Arch Intern Med 1999;159:677-685.
ABSTRACT
| FULL TEXT
Cost-effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation
Eckman et al.
Arch Intern Med 1998;158:1669-1677.
ABSTRACT
| FULL TEXT
Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation
Gage et al.
Stroke 1998;29:1083-1091.
ABSTRACT
| FULL TEXT
Thrombolytic treatment for acute ischaemic stroke: consent can be ethical
Lindley
BMJ 1998;316:1005-1007.
FULL TEXT
Quality of Life of Stroke in Younger Individuals : Utility Assessment in Patients With Arteriovenous Malformations
Shin et al.
Stroke 1997;28:2395-2399.
ABSTRACT
| FULL TEXT
